DNTH Dianthus Therapeutics, Inc.
84.88USD-0.61%Mkt Cap: 4.64B $P/E: —1d ago
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal ant…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap4.64B USD
Enterprise Value3.89B USD
Revenue (TTM)1.90M USD
Gross Profit1.90M USD
Net Income (TTM)-162.34M USD
Revenue/Share0.04 USD
Last Price84.88 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-18.52
PEG—
EV/EBITDA-17.87
EV/Revenue2043.73
P/S2451.94
P/B3.99
EPS (TTM)-4.24
EPS (Forward)-4.61
52W Range
32.2261% of range117.88
52W High117.88 USD
52W Low32.22 USD
Profitability
Gross Margin100.00%
Oper. Margin-8079.11%
EBITDA Margin0.00%
Profit Margin-7973.33%
ROE-32.90%
ROA-30.58%
Growth
Revenue Growth294.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-129.06M USD
CapEx (TTM)213.00K USD
FCF Margin-4842.99%
FCF Yield-1.99%
Net Debt-885.53M USD
Net Debt/EBITDA4.07
Balance Sheet
Debt/Equity0.00
Current Ratio26.10
Quick Ratio25.79
Book Value/Sh21.39 USD
Cash/Share15.86 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)140.80 USD
Upside (mean)+65.9%
Target Range122.00 USD – 200.00 USD
122.00+65.9% to mean200.00
# Analysts15
Ownership
Shares Out.54.67M
Float55.85M
Insiders0.12%
Institutions127.88%
Short Interest
Short Ratio15.0d
Short % Float18.11%
Short % Out.15.79%
Shares Short8.83M
Short (prev mo.)8.42M
Technical
SMA 50104.38 (-18.7%)
SMA 20081.38 (+4.3%)
Beta0.18
S&P 52W Chg16.45%
Avg Vol (30d)792.79K
Avg Vol (10d)839.43K
Technical Indicators
RSI (14)27.7
MACD-5.3113
MACD Signal-4.5387
MACD Hist.-0.7725
BB Upper111.99 USD
BB Middle95.02 USD
BB Lower78.04 USD
BB Width35.74%
ATR (14)4.549 USD
Vol Ratio (20d)0.61x